Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pacific Health Care Organization (PFHO) Liabilities and Shareholders Equity (2016 - 2025)

Pacific Health Care Organization's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $13.5 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 8.29% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $52.7 million, up 8.6%, while the annual FY2025 figure was $13.5 million, 8.29% up from the prior year.
  • Liabilities and Shareholders Equity reached $13.5 million in Q4 2025 per PFHO's latest filing, up from $13.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $13.5 million in Q4 2025 to a low of $11.2 million in Q2 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $12.0 million, with a median of $11.9 million recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: fell 4.24% in 2023, then rose 11.49% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $11.3 million in 2021, then grew by 6.35% to $12.1 million in 2022, then dropped by 2.49% to $11.8 million in 2023, then increased by 5.79% to $12.4 million in 2024, then grew by 8.29% to $13.5 million in 2025.
  • Per Business Quant, the three most recent readings for PFHO's Liabilities and Shareholders Equity are $13.5 million (Q4 2025), $13.3 million (Q3 2025), and $13.3 million (Q2 2025).